Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.

Nature Medicine

September 7, 2020

Motzer, RJ, Robbins, PB, Powles, T et al.